OTHER RELEVANT INFORMATION
PLÁSTICOS COMPUESTOS, S.A.June 18, 2025
Pursuant to the provisions of Article 17 of Regulation (EU) No. 596/2014 on Market Abuse and Article 227 of Law 6/2023, of 17 March, on Securities Markets and Investment Services, and concordant provisions, as well as Circular 3/2020 of 30 July 2020, on information to be provided by companies listed for trading on BME Growth, Plásticos Compuestos, S.A. (the "Company") hereby informs you of the following information:
On June 18, 2025, the Ordinary General Shareholders' Meeting of the Company was held at its first call, with 90.27% of the Company's capital stock and 91.43% of the Company's capital stock with voting rights in attendance and represented by proxy.
At said meeting, the resolutions of the agenda proposed by the Board of Directors contained in the notice of call published on May 16, 2025 were submitted for deliberation, having been approved, (i) by a majority of the capital present and represented, items 5, 9 and 10 of the agenda and (ii) by unanimity of the capital present and represented, the remaining items of the agenda, in relation to the following resolutions:
Ratification of the valid constitution of the Ordinary General Shareholders' Meeting, the agenda and the offices of Chairman and Secretary.
Examination and approval, if applicable, of the annual financial statements and management report for the year ended December 31, 2024.
Approval of the proposed appropriation of income for the year ended December 31, 2024.
Examination and approval of the management and performance of the Board of Directors and its Audit Committee during fiscal year 2024.
Approval of the remuneration of the members of the Board of Directors for the fiscal year 2026.
Reelection of Mr. Guillermo Ferrer Sistach as member of the Board of Directors.
Re-election of Ms. Núria Matellán Martín as member of the Board of Directors.
Appointment of the Company's auditor for fiscal years 2026, 2027 and 2028.
Authorization to the Board of Directors so that, in accordance with the provisions of Article
297.1.b) of the Capital Companies Act, it may increase the capital on one or more occasions and at any time, within a period of 5 years, by means of monetary contributions and in a maximum nominal amount of 3,646,710 euros. Delegation for the exclusion of pre-emptive subscription rights, in accordance with the provisions of Article 506 of the Capital Companies Act. Revocation of the previous authorizations.
Authorization to the Board of Directors to issue securities convertible into shares of the Company within a period of 5 years. Establishment of criteria for determining the bases and modalities of conversion and attribution of powers to increase capital. Delegation for the
exclusion of the pre-emptive subscription right, in accordance with the provisions of Article 506 of the Capital Companies Act. Revocation of previous authorizations.
Authorization for the derivative acquisition of treasury stock by the Company. Revocation of previous authorizations.
Delegation of powers.
Questions and answers.
Drafting, reading and, if applicable, approval of the minutes.
In compliance with the provisions of Circular 3/2020 of the BME Growth segment of BME MTF Equity, it is hereby expressly stated that the information provided herein has been prepared under the sole responsibility of the Company and its directors.
We remain at your disposal for any clarification you may require. In Palau-Solità i Plegamans (Barcelona), on June 18, 2025.
Corporation Chimique International S.P.R.L.
P.p. Mr. Ignacio Duch Tuesta Chairman of the Board of Directors